Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma

NCT00541840 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Sorafenib

Sponsor

Grupo Espanol de Investigacion en Sarcomas